GE HealthCare Technologies Inc. Stock Börse Stuttgart

Equities

L0T

US36266G1076

Advanced Medical Equipment & Technology

Real-time Estimate Tradegate 06:44:03 2024-05-29 am EDT 5-day change 1st Jan Change
72.22 EUR +0.22% Intraday chart for GE HealthCare Technologies Inc. -3.58% +3.13%
Sales 2024 * 20.17B 18.6B Sales 2025 * 21.17B 19.52B Capitalization 35.95B 33.15B
Net income 2024 * 1.86B 1.71B Net income 2025 * 2.12B 1.96B EV / Sales 2024 * 2.04 x
Net Debt 2024 * 5.14B 4.74B Net Debt 2025 * 3.11B 2.87B EV / Sales 2025 * 1.85 x
P/E ratio 2024 *
19.4 x
P/E ratio 2025 *
17.1 x
Employees 51,000
Yield 2024 *
0.1%
Yield 2025 *
0.24%
Free-Float 93.07%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.21%
1 week-3.58%
Current month-3.98%
1 month-11.90%
3 months-14.57%
6 months+18.34%
Current year+3.13%
More quotes
1 week
72.17
Extreme 72.17
74.85
1 month
72.03
Extreme 72.03
83.28
Current year
65.00
Extreme 65
86.50
1 year
58.50
Extreme 58.5
86.50
3 years
51.81
Extreme 51.81
86.50
5 years
51.81
Extreme 51.81
86.50
10 years
51.81
Extreme 51.81
86.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 22-12-13
Director of Finance/CFO 51 23-05-31
Chief Tech/Sci/R&D Officer - 22-09-30
Members of the board TitleAgeSince
Director/Board Member 65 22-12-13
Chief Executive Officer 59 22-12-13
Chairman 60 23-01-02
More insiders
Date Price Change Volume
24-05-29 72.19 +0.18% 197
24-05-27 72.38 -1.40% 351
24-05-23 73.41 -1.95% 100
24-05-22 74.87 -0.07% 53

Delayed Quote Börse Stuttgart, May 29, 2024 at 05:49 am EDT

More quotes
GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. It develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment portfolio is comprised of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment is comprised of two business lines: contrast media and molecular imaging.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
78.75 USD
Average target price
93.18 USD
Spread / Average Target
+18.32%
Consensus